Vimarsana
Biggest News Aggregation in the World

Page 16 - Accessed August News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accessed August. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accessed August Today - Breaking & Trending Today

Roche, Healthway Medical Network of Ayala Healthcare Holdings, Inc. inks landmark partnership to transform cancer care - Vimarsana News

Roche, Healthway Medical Network of Ayala Healthcare Holdings, Inc. inks landmark partnership to transform cancer care

Responding to the rising needs of Filipino Patients, two healthcare ecosystem leaders with the shared vision of catalyzing impactful changes in cancer care collaborated through a first-of-its-kind network-wide partnership. Roche (Philippines) Inc. Pharmaceuticals Division General Manager Dr. Diana M. Edralin, Roche Philippines Patient Journey Chapter Lead (PJCL) Mr. Raymon Cayabyab,…

Study Details Risk of C Diff with Clindamycin, Other Antibiotics - Vimarsana News

Study Details Risk of C Diff with Clindamycin, Other Antibiotics

Results from the study found a high risk of CDI associated with clindamycin and low risk associated with doxycycline and minocycline, also highlighting variation in CDI risk within and between classes of antibiotics.

UCB : presents new data at 35th International Epilepsy Congress (IEC) highlighting important advancements across Fintepla▼(fenfluramine) oral solution and broader epilepsies portfolio -Today at 01:04 am - Vimarsana News

UCB : presents new data at 35th International Epilepsy Congress (IEC) highlighting important advancements across Fintepla▼(fenfluramine) oral solution and broader epilepsies portfolio -Today at 01:04 am

Was conducted to examine the efficacy of fenfluramine on GTCS reduction in various types of Developmental and Epileptic Encephalopathies or rare epilepsy conditions. Data from 13 studies , 4...

ENHERTU® Granted Two Breakthrough Therapy Designations in U.S. for Patients Across Multiple HER2 Expressing Cancers - Vimarsana News

ENHERTU® Granted Two Breakthrough Therapy Designations in U.S. for Patients Across Multiple HER2 Expressing Cancers

Designations for Daiichi Sankyo and AstraZeneca's ENHERTU include patients with HER2 expressing metastatic solid tumors and HER2 positive metastatic colorectal cancer ENHERTU has now been granted...

Atopic Dermatitis Associated With Increased Risk of IBD - Vimarsana News

Atopic Dermatitis Associated With Increased Risk of IBD

A population-based cohort study highlighted an association between AD and IBD with risk varying by age, AD severity, and subtype of IBD.